Valeriana officinalis Extracts Ameliorate Neuronal Damage by Suppressing Lipid Peroxidation in the Gerbil Hippocampus Following Transient Cerebral Ischemia

Journal of Medicinal Food
Dae Young YooIn Koo Hwang

Abstract

As a medicinal plant, the roots of Valeriana officinalis have been used as a sedative and tranquilizer. In the present study, we evaluated the neuroprotective effects of valerian root extracts (VE) on the hippocampal CA1 region of gerbils after 5 min of transient cerebral ischemia. Gerbils were administered VE orally once a day for 3 weeks, subjected to ischemia/reperfusion injury, and continued on VE for 3 weeks. The administration of 100 mg/kg VE (VE100 group) significantly reduced the ischemia-induced spontaneous motor hyperactivity 1 day after ischemia/reperfusion. Four days after ischemia/reperfusion, animals treated with VE showed abundant cresyl violet-positive neurons in the hippocampal CA1 region when compared to the vehicle or 25 mg/kg VE-treated groups. In addition, the VE treatment markedly decreased microglial activation in the hippocampal CA1 region 4 days after ischemia. Compared to the other groups, the VE100 group showed the lowest level of lipid peroxidation during the first 24 h after ischemia/reperfusion. In summary, the findings in this study suggest that pretreatment with VE has protective effects against ischemic injury in the hippocampal pyramidal neurons by decreasing microglial activation and lipid per...Continue Reading

References

Jul 1, 1989·Stroke; a Journal of Cerebral Circulation·C BromontJ Bralet
Jan 1, 1985·Psychopharmacology·G Balderer, A A Borbély
Sep 1, 1985·Journal of Pharmacological Methods·M J ChandlerJ M Carney
Jul 1, 1993·Behavioral and Neural Biology·L E Jarrard
Apr 16, 1998·Neurologia Medico-chirurgica·R L Macdonald, M Stoodley
Dec 23, 1998·Proceedings of the National Academy of Sciences of the United States of America·J YrjänheikkiJ Koistinaho
May 26, 1999·Progress in Neurobiology·G Stoll, S Jander
May 26, 1999·Progress in Neurobiology·F Block
Apr 18, 2000·Sleep Medicine·C Stevinson, E Ernst
Feb 13, 2003·Journal of Neuropathology and Experimental Neurology·Gary H Danton, W Dalton Dietrich
Mar 23, 2004·Current Molecular Medicine·Chainllie YoungJohn W Olney
Aug 25, 2004·Neurotoxicity Research·João O MalvaTice Macedo
Jun 15, 2005·Molecular Neurobiology·Atsushi SaitoPak H Chan
Aug 16, 2006·Phytotherapy Research : PTR·Nadia J Jacobo-HerreraMichael Heinrich
May 31, 2008·Neurochemical Research·Diêgo Madureira de OliveriaLisandro Diego Giraldez
Jun 25, 2008·Neuropharmacology·R W V FlynnA S F Doney
Feb 5, 2009·Neurochemical Research·Jéssie Haigert SudatiJoão Batista Teixeira Rocha
Sep 16, 2009·Biochimica Et Biophysica Acta·Neil R Sims, Hakan Muyderman
Feb 5, 2010·Journal of Leukocyte Biology·Rong JinGuohong Li
Mar 15, 2011·The European Journal of Neuroscience·Katharina MerzD Chichung Lie
Apr 9, 2011·Journal of Neural Transmission·Romaiana Picada PereiraJoão Batista Teixeira Rocha
May 4, 2013·Neurotoxicology·Jéssie Haigert SudatiNilda Vargas Barbosa

❮ Previous
Next ❯

Software Mentioned

Photobeam
Optimas

Related Concepts

Related Feeds

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.